Pediatrix Medical Group, Inc. (MD)
NYSE: MD · Real-Time Price · USD
14.49
+0.33 (2.33%)
Mar 31, 2025, 4:00 PM EDT - Market closed
Pediatrix Medical Group Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for Pediatrix Medical Group stock have an average target of 17.08, with a low estimate of 15 and a high estimate of 18.5. The average target predicts an increase of 17.87% from the current stock price of 14.49.
Analyst Consensus: Buy
* Price targets were last updated on Feb 21, 2025.
Analyst Ratings
The average analyst rating for Pediatrix Medical Group stock from 6 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 1 | 1 | 1 | 1 |
| Hold | 5 | 5 | 5 | 5 | 5 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 7 | 7 | 7 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Hold Maintains $17 → $19 | Hold | Maintains | $17 → $19 | +27.67% | Feb 21, 2025 |
| Truist Securities | Truist Securities | Hold Maintains $15 → $18 | Hold | Maintains | $15 → $18 | +24.22% | Feb 21, 2025 |
| Truist Securities | Truist Securities | Hold Maintains $16 → $15 | Hold | Maintains | $16 → $15 | +3.52% | Jan 6, 2025 |
| Macquarie | Macquarie | Buy Initiates $18 | Buy | Initiates | $18 | +24.22% | Dec 16, 2024 |
| Mizuho | Mizuho | Hold Maintains $13 → $15 | Hold | Maintains | $13 → $15 | +3.52% | Nov 19, 2024 |
Financial Forecast
Revenue This Year
1.92B
from 2.01B
Decreased by -4.62%
Revenue Next Year
1.97B
from 1.92B
Increased by 2.76%
EPS This Year
1.59
from -1.19
EPS Next Year
1.67
from 1.59
Increased by 5.39%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 2.1B | 2.1B | 2.3B | ||
| Avg | 1.9B | 2.0B | 2.1B | ||
| Low | 1.8B | 1.8B | 1.9B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 2.4% | 11.1% | 15.0% | ||
| Avg | -4.6% | 2.8% | 5.1% | ||
| Low | -12.3% | -6.4% | -5.6% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 1.70 | 1.89 | 2.10 | ||
| Avg | 1.59 | 1.67 | 1.69 | ||
| Low | 1.38 | 1.40 | 1.36 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | 18.7% | 25.4% | ||
| Avg | - | 5.4% | 1.2% | ||
| Low | - | -11.8% | -18.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.